Bioxcel therapeutics to participate at two upcoming investor conferences

New haven, conn., june 01, 2023 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that vimal mehta, ph.d., ceo of bioxcel therapeutics, will participate in fireside chats at two upcoming investor conferences. he will be joined by robert risinger, m.d., chief medical officer, neuroscience, and matt wiley, chief commercial officer.
BTAI Ratings Summary
BTAI Quant Ranking